ENTA - Financial Reports List - Enanta Pharmaceuticals, Inc. - IntrinsicAlpha

Enanta Pharmaceuticals, Inc. ENTA

Healthcare - Biotechnology - NASDAQ - US

$ 5.23

2.55 %

$ 112 M

Market Cap

-1.06

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2024-12-31	-5.80%	33.28%	32.51%
Quarterly Report	Q4	8-K	2024-09-30	-22.84%	-2.55%	3.79%
Annual Report	FY	10-K	2024-09-30	-14.61%	13.28%	11.31%
Quarterly Report	Q3	8-K	2024-06-30	-4.88%	42.00%	34.12%
Quarterly Report	Q2	8-K	2024-03-31	-4.16%	17.26%	16.95%
Quarterly Report	Q1	8-K	2023-12-31	-23.67%	-15.25%	-16.24%
Quarterly Report	Q4	8-K	2023-09-30	-6.82%	-6.68%	-14.72%
Annual Report	FY	10-K	2023-09-30	-8.07%	-9.91%	-10.79%
Quarterly Report	Q3	8-K	2023-06-30	-3.01%	-23.23%	-12.82%
Quarterly Report	Q2	8-K	2023-03-31	-4.92%	-12.96%	-16.56%

1